In Re: Aggrenox Antitrust Litigation

Track this case

Case overview

Case Number:

3:14-md-02516

Court:

Connecticut

Nature of Suit:

Anti-Trust

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Stefan R Underhill

Firms

Companies

Sectors & Industries:

  1. March 23, 2015

    Teva, Boehringer Trim 'Frankensteinian' Aggrenox Claims

    A Connecticut judge on Monday kept intact most federal claims against Teva Pharmaceuticals USA Inc. and Boehringer Ingelheim Pharmaceuticals Inc. alleging a pay-for-delay scheme over a generic version of stroke drug Aggrenox but gutted a "hodgepodge" of state claims the judge compared to Frankenstein's monster.

  2. July 16, 2014

    Teva Says It Doesn't Belong In Pay-For-Delay MDL

    Teva Pharmaceutical Industries Ltd. has asked a Connecticut federal court to be dismissed from antitrust class actions alleging a pay-for-delay scheme over a generic version of stroke drug Aggrenox, saying it is an Israeli company with only slight dealings with domestic subsidiaries accused of participating in the scheme.